![]()
|
Report Date : |
29.11.2007 |
IDENTIFICATION
DETAILS
|
Name : |
MEDIFARMA LTDA |
|
|
|
|
Registered Office : |
Avenida Ahmed Sekou Toure 451 Maputo |
|
|
|
|
Country : |
Mozambique |
|
|
|
|
Date of Incorporation : |
06/05/1999 |
|
|
|
|
Com. Reg. No.: |
106768 |
|
|
|
|
Legal Form : |
Limited
Liability Company, Limited by shares |
|
|
|
|
Line of Business : |
Manufacturers
& distributors pharmaceutical products and Medicines |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 60,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
MEDIFARMA LTDA
Avenida Ahmed Sekou Toure 451 Maputo Mozambique
Telephone: +258-21-485678/ 80 /81
Fax: +258-21-485678
Email: ganapathi@medifarma.co.mz
Internet: www.medifarma.co.mz or www.astrazeneca.com
06/05/1999
No.106768 Maputo
Mozambique
limited Liability
company, Limited by shares
Not Listed
2006
80
Head offices 451,r/c Avenida Ahmed Sekou Toure, Maputo Mozambique
Branches 954 Avenida 24 Julho, Maputo Mozambique
Paid in Capital MZM. 1,000,000,000
Subscribed Capital MZM. 1,000,000,000
Name Position Amount
Ratio
Mr. Ganapathi
Subramanian CEO 50.00%
Mrs. P Subramanian Director 50.00%
Total 100.00%
Our proposed credit amount of USD 60,000 is recommendable
None
|
President/
CEO (1) |
|
|
Name |
Mr. Ganapathi Subramanian |
|
Remarks |
Top Decision Maker |
Þ Top decision maker is the person who has the ultimate authority or power to make important managerial decisions. He/She may or may not be officially registered as a president or an executive director.
Manufacturers
& distributors pharmaceutical products and Medicines
Buying terms 30% in cash, 70% on credit
Selling terms 80% in cash, 20% on credit
None
Local agencies, stores and
outlets
MZM. 54,000,000,000
(2006)
None
Export Ratio 0.0%
Import Ratio 20.0%
Domestic Market Share 40.0%
Main Banks MCB Bank
Payment Morale : In the documents at our
disposal nothing adverse has been shown so far.
CREDIT RATING : Financial situation is
average.
Maximum credit we recommend is USD 60,000 outstanding at any one time.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to
assess SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial condition (40%) Ownership background (20%) Payment
record (10%)
Credit history (10%) Market trend (10%) Operational
size (10%)